Opportunity to buy Osiris at discount price - update March 11, 2013
New Venturetec (NEV.SW) is an investment company incorporated in Zurich. Pursuant to New Venturetec, the company holds through its subsidiary Venturetec 4'103'301 shares of Osiris Therapeutics. As of March 11, 2013 this holding represents 61.8% of the total Portfolio of New Venturetec. If all the other positions would be worthless, the NAV actually would stand at 4,34. In this moment NEV.SW stands at ask/bid 4.11/4.18. So buying New Venturetec you'll get the Osiris shares cheaper then buying them directly at USD 9.55, and in addition you'll get the other part of the New Venturetec portfolio for free.
Under the following links you can do your own due diligence:
of course your calculation is correct ! we usually trade nev at 50 % of osir price. now we are clearly undervalued. it may have to do with basler versicherung unloading their position and little buying at the moment. things will correct over time though